Skip to main content

Okla. Opioid Crisis: AG To Refile Case In State Court

Okla. Opioid Crisis: AG To Refile Case In State Court

Okla. Opioid Crisis: AG To Refile Case In State Court

Introduction

On Friday, Oklahoma Attorney General Mike Hunter voluntarily dismissed the opioid lawsuit against three distributors that have been moved to federal court and will refile new lawsuits in state court against each company individually.

Opioids are on the market for ages and have been used basically for pain relief for post-surgical pain, cancer-related pain, chronic or persistent pain. Opioids when used in proper dosage and along with a combination of other pain treatments, work in relieving pain successfully, unless there is a misuse or abuse of the drug.

Companies manufacturing opioids convinced the medical community that these medications were not addictive and were purely beneficial. This belief raised the number of prescriptions and sales unwarrantedly, resulting in a mass misuse of these drugs, to the extent that this was identified by the U.S. Food and Drug Administration (FDA) as a public issue and named it an opioid crisis.

The companies McKesson Corp., Cardinal Health, and AmerisourceBergen were sued in mid-January for allegedly fueling the opioid crisis in the state by ignoring suspicious orders of painkillers. 

The notice came three weeks after the case was removed from Cleveland County District Court to the Oklahoma federal court.

In recent months, Oklahoma reaped some massive settlements, beginning with Purdue Pharma LP and Teva Pharmaceuticals, which made a settlement of $270 million and $85 million, respectively, followed by a $572 million verdict against Johnson & Johnson by an Oklahoma state judge, which was later cut to $465 million. Lastly, Endo Pharmaceuticals Inc. made an $8.75 million out-of-court deal with the state to avoid legal action.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!